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Myeloid-derived suppressor cells (MDSCs) are one of the major negative regulators of immune responses. In
this issue of Immunity, Thevenot et al. (2014) showed that in tumors, the suppressive activity of MDSCs is
regulated by transcription factor Chop.The endoplasmic reticulum (ER) stress
response is an evolutionary conserved
process designed to protect cells from
stress signals including starvation, viral in-
fections, and changes in oxygen tension.
Protein synthesis and folding takes place
in the ER. Only correctly folded proteins
are exported to the Golgi apparatus.
Incorrectly folded proteins activate the
unfolded protein response, which in
eukaryotes is initiated by three major
sensors: (1) PERK (protein kinase RNA
(PKR)-like ER kinase), which phosphory-
lates eukaryotic protein synthesis initiation
factor 2 (eIF2a), which in turn activates the
expressionof the transcription factorATF4
and its downstream targets, including
Chop (C/EBPhomologousprotein) (Walter
and Ron, 2011); (2) IRE1 (inositol-requiring
enzyme 1), which cleaves the mRNA en-
coding for the transcription factor X-box-
binding protein-1 (Xbp1); spliced XBP1
(sXBP1) mRNA is then ligated by RNA
ligase and translated to produce sXbp1
protein (Cla´udio et al., 2013); and (3)
ATF6 (activating transcription factor 6),
which induces the transcription of ER
chaperone genes, such as Bip and several
major targets, including sXbp1.
In recent years, it has been shown that
the ER stress response can be developed
without substantial involvement of the
unfolded protein response (Cla´udio et al.,
2013).Mahadevan et al. (2011) have previ-
ously demonstrated that ER stress can
be transmitted from tumor cells to
macrophages. This resulted in enhanced
immune-suppressive activity of macro-
phages. This process imprinted dendritic
cells with a more tolerogenic phenotype
characterized by a decreased ability to
cross-present antigen to CD8+ T cells
(Mahadevan et al., 2012). However, those
experiments were performed in cells afterin vitro treatment with conditioned media
from tumor cells exposed to ER stress in-
ducers. The question remained as to
whether the ER stress response could be
detected in myeloid cells in vivo and
whether it had functional consequences.
We recently have found that MDSCs
showclear signsof theERstress response
(Condamine et al., 2014). In contrast to
their control counterparts, neutrophils
and monocytes, freshly isolated MDSCs
from the bone marrow and spleens of
tumor-bearing mice and from the periph-
eral blood of cancer patients demon-
strated upregulation of Chop and sXBP1.
This upregulation was linked to the short
lifespan of MDSCs (Condamine et al.,
2014). However, the question remained
whether ER stress could be responsible
for the immune-suppressive activity of
MDSCs, a hallmark of these cells.
The current study by Thevenot et al.
(2014) attempts to address this question.
Thevenotet al. (2014) have focusedspecif-
ically on one factor: Chop. They demon-
strate that in tumors, Chop is mainly
expressed by infiltrating myeloid cells.
They showed that the growth of several
transplantable tumors was significantly
retarded in Chop-deficient mice as
compared to wild-type mice. This phe-
nomenon was reproduced in congenic
mice reconstituted with bone marrow
from Chop-deficient mice. Interestingly,
MDSC depletion was able to partially
restore tumor growth in Chop-deficient
mice, suggesting that the decreased
tumor growth could be attributed to a
reversal of MDSC activity. No difference
was observed in the presence of MDSCs
in thespleensof tumor-bearingChop-defi-
cient mice, compared to wild-type. How-
ever, Thevenot et al. (2014) found an
increased proportion of MDSCs, but notImmunity 41, Semacrophages, inside the tumor and linked
it to an increased survival of Chop-defi-
cient MDSCs. Consistent with the demon-
strated effect of MDSC depletion in Chop-
deficientmice,whenThevenot et al. (2014)
assessed the suppressive activities of
tumor-infiltrating MDSCs, they observed
a complete loss of suppressive activity in
these cells. This loss of suppressive ability
was associated with a strong decrease in
arginase-1 and reactive oxygen species
(ROS). Furthermore, MDSCs derived
from Chop-deficient mice acquired a DC-
like phenotype and were able to stimulate
immune response both in vitro and in vivo.
More IFN-g-producing CD8+ T cells were
recruited to the tumor in Chop-deficient
mice and the depletion of CD8+ cells
cancelled the retardation of tumor growth
in Chop-deficient mice. MDSCs from
Chop-deficient mice were able to function
as antigen-presenting cells both in vivo
and in vitro. ROS and peroxynitrite (PNT)
present in the tumor microenvironment
were implicated in the increase in Chop
expression. The authors also analyzed
the molecular pathway responsible for
Chop upregulation and demonstrated
that the increase in Chop expression was
associated with increased phosphoryla-
tion of eIF2a. Furthermore, Chop upregu-
lation was abrogated in ATF4-deficient
mice, clearly implicating the PERK path-
way of the ER stress response. In the
absence of Chop, the activity of C/EBPb,
pSTAT3, and the production of IL-6 were
all strongly decreased. Treatment of mice
with IL-6 was able to restore both tumor
growth and the suppressive activity of
MDSCs in Chop-deficient mice, suggest-
ing that Chop could regulate MDSC func-
tion by modulating the production of IL-6.
This study presents a novel and exciting
mechanism of regulation of MDSC activityptember 18, 2014 ª2014 Elsevier Inc. 341
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Figure 1. Possible Role of Chop in Regulation of MDSC Function
Potential mechanism of Chop involvement in T cell suppression. Main population of MDSCs in bone
marrow and lymphoid organs are PMN-MDSCs. These cells have modestly increased amount of Chop
and suppress antigen-specific T cells via direct cell-cell contact. In tumor sites, cells are exposed to
factors causing strong upregulation of Chop, which results in release of soluble factors driving antigen
nonspecific T cell suppression. Question marks denote yet-to-be-defined increase in Chop expression
in macrophage, PMN-MDSC, or T cell.
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Previewsin cancer. However, it raises a number
of issues that should stimulate further
investigations.
The first issue is the possible impact of
host Chop deficiency on tumor progres-
sion. Since we have observed upregula-
tion of Chop in MDSCs (Condamine
et al., 2014), we have earlier performed a
number of experiments using Chop-
deficient mice from the same source and
tested them in experimental setting
similar to those described by Thevenot
et al. (2014) including reconstitution with
Chop-null bone marrow cells. However,
we could not observe any difference in
tumor growth. The reason for this
discrepancy is not clear. It is possible
that difference in housing conditions and
microbiota may affect the results.
The second issue is lack of the Chop
effect on spleen MDSCs. Thevenot et al.
(2014) did not observe any differences
in MDSC accumulation in spleens be-
tween wild-type and Chop-deficient mice
despite a very strong difference in tumor
size. MDSC accumulation is known to
correlate closely with the tumor size, so
one could expect decreased presence of
MDSCs in spleensofChop-deficientmice.
The third issue is the regulation of im-
mune-suppressive effects of MDSCs by
Chop. Thevenot et al. (2014) observed
the effect of Chop only in tumor MDSCs
by measuring antigen nonspecific sup-342 Immunity 41, September 18, 2014 ª2014pression of these cells. However, it is
known that splenic MDSCs are very poor
suppressors of nonspecific CD3- and
CD28-induced T cell proliferation (Corzo
et al., 2010). Therefore, it was not surpris-
ing that Thevenot et al. (2014) did not
detect any suppressive activity in these
cells. However, when we performed
similar experiments usingantigen-specific
T cell response, splenic MDSCs potently
inhibited T cell proliferation and the
absence of Chop did not affect this sup-
pression despite the fact that, as previ-
ously reported, splenic MDSCs had upre-
gulation of Chop (Condamine et al., 2014).
Thevenot et al. (2014) did not evaluate
the role of Chop in function of different
groups of MDSCs. It is now established
that granulocytic cells represent a pre-
dominant population of MDSCs in spleen.
However, in tumor sites, monocytic cells
are more prominent than in spleen. The
suppressive mechanisms used by these
two groups of cells are quite different. It
would be important to establish whether
the effect of Chop is limited to only one
group of MDSCs or whether differences
in functional activity reflects composition
of MDSCs in tumor site.
Thus, these data may suggest an alter-
nate mechanism of Chop involvement
in MDSC-mediated immune suppression
(Figure 1). Cancer is associated with the
ER stress response in MDSCs. It can beElsevier Inc.seen in the bone marrow and spleens of
tumor-bearing mice and in peripheral
blood from cancer patients. Chop upre-
gulation is part of this response. It
appears that upregulation of Chop in
MDSCs does not affect their ability to
suppress antigen-specific immune re-
sponses. The cause for Chop upregula-
tion in these cells remains to be
established. At the tumor site, MDSCs
are exposed to multiple factors that are
able to induce the potent ER stress
response (hypoxia, nutrient deprivation,
etc.). Under these conditions, profound
upregulation of Chop appears to reach
a threshold that leads to the potent anti-
gen nonspecific suppressive activity of
MDSCs. However, it is rather unlikely
that this effect would be specific to
MDSCs given the nature of factors
involved (Figure 1). Careful analysis of
Chop expression and its effect on the
immune-suppressive activity of tumor-
associated macrophages and the func-
tion of tumor-infiltrating T lymphocytes
will be necessary. It is possible that
Chop upregulation at the tumor site re-
flects a shared mechanism affecting all
immune cells. This would be consistent
with the concept of compartmentalization
of immune suppression in cancer. Thus, it
appears that the ER stress response is an
important factor regulating the immune-
suppressive function of myeloid cells in
cancer, but the nature of its involvement
requires further clarification.
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